BIOQUAL, Inc.
BIOQ
$55.00
-$1.00-1.79%
| 11/30/2024 | 08/31/2024 | 11/30/2023 | 11/30/2023 | 05/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -9.33% | -9.33% | -5.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -9.33% | -9.33% | -5.27% |
| Cost of Revenue | -- | -- | 0.80% | 0.80% | 2.25% |
| Gross Profit | -- | -- | -38.40% | -38.40% | -26.69% |
| SG&A Expenses | -- | -- | 8.88% | 8.88% | 7.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 2.23% | 2.23% | 3.26% |
| Operating Income | -- | -- | -114.03% | -114.03% | -83.12% |
| Income Before Tax | -- | -- | -110.90% | -110.90% | -82.77% |
| Income Tax Expenses | -- | -- | -120.53% | -120.53% | -77.38% |
| Earnings from Continuing Operations | -- | -- | -108.44% | -108.44% | -84.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -108.44% | -108.44% | -84.12% |
| EBIT | -- | -- | -114.03% | -114.03% | -83.12% |
| EBITDA | -- | -- | -81.78% | -81.78% | -59.00% |
| EPS Basic | -- | -- | -108.44% | -108.44% | -84.12% |
| Normalized Basic EPS | -- | -- | -110.90% | -110.90% | -82.77% |
| EPS Diluted | -- | -- | -108.55% | -108.55% | -84.19% |
| Normalized Diluted EPS | -- | -- | -110.90% | -110.90% | -82.77% |
| Average Basic Shares Outstanding | -- | -- | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -- | -- | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -50.00% | -50.00% | -50.00% |
| Payout Ratio | -- | -- | -6.92% | -6.92% | 4.04% |
